Skip to main content

Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial

The Original Article was published on 08 May 2023

Correction: Pilot Feasibility Stud 9, 78 (2023)

https://doi.org/10.1186/s40814-023-01311-4

Following publication of the original article [1], the authors identified an error in Table 2. The correct table is given below.

Table 2 Erase Hep C study SPIRIT figure

The original article [1] has been updated.

Reference

  1. Desai A, O’Neal L, Reinis K, et al. Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study — a prospective single-arm intervention trial. Pilot Feasibility Stud. 2023;9:78. https://doi.org/10.1186/s40814-023-01311-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tim Mercer.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desai, A., O’Neal, L., Reinis, K. et al. Correction: Development, implementation, and feasibility of site‑specific hepatitis C virus treatment workflows for treating vulnerable, high‑risk populations: protocol of the Erase Hep C study — a prospective single‑arm intervention trial. Pilot Feasibility Stud 9, 108 (2023). https://doi.org/10.1186/s40814-023-01347-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40814-023-01347-6